VoICE Immunization Evidence: Health security
A strong national immunization program can be leveraged during critical health emergencies to aid in outbreak response.
The detection of H1N1 influenza virus in Mexico in 2009, and subsequently throughout other countries in the Americas, benefited from the laboratory experience with measles and rubella in the region, leading to the rapid detection of and response to what eventually became a novel pandemic virus.
Immunization globally provides a key opportunity to control emerging disease outbreaks and prevent the spread of disease across national borders.
Vaccines against yellow fever and cholera continue to be critical to managing outbreaks of disease and protecting national and international health security.
Conflict in the Eastern Mediterranean Region impacted health infrastructure and compromised the success of the region’s measles elimination goal. At the same time that rates of migration and displacement skyrocketed, the number of measles cases in the region doubled, from 10,072 cases in 2010 to 20,898 in 2015.
In 2013 nearly all of the 175 cases of measles in the US could be traced back to international importations.
World travel can perpetuate the spread of multi-drug resistant strains of disease that could be prevented through immunization.
TB and pneumococcal infections are two of 18 drug-resistant threats to US health security identified by the CDC in 2013 and are potentially vaccine-preventable. Most antibiotic resistant TB infections in the US occur in people born outside the US.